Merck 2008 Annual Report Download - page 32

Download and view the complete annual report

Please find page 32 of the 2008 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 153

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153

MANAGEMENT REPORT OF THE MERCK GROUP 27
24 Responsibility
26 Merck shares
30 Pharmaceuticals business sector
50 Chemicals business sector
12 Overall economic situation
14 Economic development
of Merck
15 Financial position and results
of operations
60 Corporate and Other
61 Risk report
64 Report on expected developments
64 Subsequent events
www.merck.de/investors
T
he per
f
ormance o
f
Merck shares vs. the D
A
X
®
/
Bl
oom
b
erg
Ph
armaceut
i
ca
l
s
I
n
d
ex
i
n 200
8
i
n
%
J
an
.
M
arc
h
J
un
e
S
e
p
t
.
Dec.
1
2
0
1
0
0
80
6
0
Share data1
2008 2007
Earnings per share after tax and
minority interest from continuing operations (in €) 1.69 –0.50
Earnings per share after tax and minority interest from continuing and
discontinued operations (in €) 1.69 16.21
Dividend in € 1.50 1.20
One-time bonus in € 2.00
Share price high in € (January 9, 2008/June 15, 2007) 93.79 106.55
Share price low in € (November 21, 2008/January 2, 2007) 57.67 79.96
Year-end share price in € 64.51 88.30
Actual number of shares in millions (as of year-end) 64.6 64.6
Theoretical total number2 of shares in millions (as of year-end) 217.4 217.4
Market capitalization3 in € million (as of year-end) 14,024 19,196
1 Share-price relevant figures relate to the closing price in Xetra® trading on the Frankfurt Stock Exchange.
2 The calculation of the theoretical number of shares is based on the fact that the general partner‘s equity capital is not represented
by shares. As the share capital of € 168.0 million was divided into 64.6 million shares, the corresponding calculation for the general
partner‘s capital of € 397.2 million resulted in 152.8 million theoretical shares on December 31, 2008.
3 Based on the theoretical number of shares.
Established in the DAX®
The liquidity of our shares remained at a high level in 2008. On average, 744,506 shares
were traded daily. High liquidity makes Merck shares attractive for more investors.
At the end of 2008, Merck again ranked 24th in the DAX® with respect to market capi-
talization, and 30th once again with respect to average share trading volumes.
Bloomberg Europe
Pharmaceuticals Index
DAX®
Merck